BDS

Banco de Sabadell Portfolio holdings

AUM $170M Turnover 1.61%
1-Year Est. Return 26.61%
This Fund
S&P 500
This Quarter Est. Return
+10.9%
1 Year Est. Return
+26.61%
3 Year Est. Return
+75.08%
5 Year Est. Return
+103.03%
10 Year Est. Return
–
AUM
$132M
AUM Growth
+$16.5M
Cap. Flow
+$4.35M
Cap. Flow %
3.3%
Top 10 Hldgs %
31.17%
Holding
85
New
3
Increased
30
Reduced
46
Closed
3
Avg Time Held
4.3 years
Top 10 Avg Time Held
2.5 years
Top 20 Avg Time Held
2.2 years

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$2.13M
2
ASML icon
ASML
ASML
+$2.08M
3
BDX icon
Becton Dickinson
BDX
+$1.49M
4
PFE icon
Pfizer
PFE
+$1.05M
5
KO icon
Coca-Cola
KO
+$336K

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$823K
2
BAX icon
Baxter International
BAX
+$599K
3
SYY icon
Sysco
SYY
+$584K
4
AAPL icon
Apple
AAPL
+$583K
5
TXN icon
Texas Instruments
TXN
+$304K

Sector Composition

Rank Sector Weight
1 Technology 25.55%
2 Healthcare 17.67%
3 Consumer Staples 11.12%
4 Financials 10.61%
5 Consumer Discretionary 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MSFT icon
1
Microsoft
MSFT
$3.96T
$7.03M 5.33%
18,696
-2,311
-11% -$823K
2017 Q4
24 quarters
AAPL icon
2
Apple
AAPL
$5.01T
$6.12M 4.65%
31,803
-3,157
-9% -$583K
2017 Q4
24 quarters
UNH icon
3
UnitedHealth
UNH
$355B
$3.97M 3.02%
7,547
-38
-0.5% -$20.3K
2017 Q4
24 quarters
ACN icon
4
Accenture
ACN
$132B
$3.9M 2.96%
11,128
+194
+2% +$62.5K
2017 Q4
24 quarters
ETN icon
5
Eaton
ETN
$159B
$3.79M 2.88%
15,727
-291
-2% -$64.2K
2017 Q4
24 quarters
MA icon
6
Mastercard
MA
$528B
$3.42M 2.6%
8,027
+130
+2% +$52.2K
2017 Q4
24 quarters
JPM icon
7
JPMorgan Chase
JPM
$890B
$3.41M 2.58%
20,030
-943
-4% -$143K
2017 Q4
24 quarters
GOOGL icon
8
Alphabet (Google) Class A
GOOGL
$4.25T
$3.33M 2.53%
23,819
+377
+2% +$50.7K
2017 Q4
24 quarters
AVGO icon
9
Broadcom
AVGO
$1.65T
$3.06M 2.32%
27,390
+450
+2% +$42.6K
2020 Q3
13 quarters
COST icon
10
Costco
COST
$435B
$3.05M 2.31%
4,613
+71
+2% +$42.1K
2017 Q4
24 quarters
LLY icon
11
Eli Lilly
LLY
$1.08T
$2.86M 2.17%
4,909
-74
-1% -$43.2K
2017 Q4
24 quarters
BAC icon
12
Bank of America
BAC
$359B
$2.67M 2.03%
79,347
+1,248
+2% +$36.3K
2017 Q4
24 quarters
CVX icon
13
Chevron
CVX
$436B
$2.6M 1.98%
17,474
-295
-2% -$44.6K
2017 Q4
24 quarters
NOBL icon
14
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.4B
$2.49M 1.89%
52,384
+6,980
+15% +$313K
2021 Q2
10 quarters
BLK icon
15
Blackrock
BLK
$166B
$2.48M 1.88%
3,056
+53
+2% +$37K
2017 Q4
24 quarters
LHX icon
16
L3Harris
LHX
$44.2B
$2.43M 1.85%
11,542
+178
+2% +$33.4K
2017 Q4
24 quarters
ASML icon
17
ASML
ASML
$634B
$2.38M 1.81%
+3,154
New +$2.08M
2023 Q4
0 quarters
DVY icon
18
iShares Select Dividend ETF
DVY
$22.8B
$2.36M 1.79%
20,122
+933
+5% +$103K
2022 Q2
6 quarters
AMZN icon
19
Amazon
AMZN
$2.74T
$2.3M 1.75%
15,130
-1,697
-10% -$238K
2017 Q4
24 quarters
AMGN icon
20
Amgen
AMGN
$230B
$2.25M 1.71%
+7,816
New +$2.13M
2023 Q4
0 quarters
HD icon
21
Home Depot
HD
$295B
$2.24M 1.7%
6,490
+110
+2% +$34.1K
2017 Q4
24 quarters
TGT icon
22
Target
TGT
$70.6B
$2.23M 1.7%
15,655
+2,440
+18% +$298K
2020 Q3
13 quarters
KO icon
23
Coca-Cola
KO
$395B
$2.18M 1.66%
37,072
+5,913
+19% +$336K
2017 Q4
24 quarters
CSX icon
24
CSX Corp
CSX
$89.4B
$2.15M 1.63%
61,915
+2,227
+4% +$70.9K
2017 Q4
24 quarters
NVO icon
25
Novo Nordisk
NVO
$168B
$2.15M 1.63%
20,752
-54
-0.3% -$5.34K
2017 Q4
24 quarters
1
2 3 4

Similar funds

WBCM
Wilson & Boucher Capital Management Moraga, California $170M AUM 28.6% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
NL
NDWM LLC La Jolla, California $170M AUM 17.06% 1-Year Est. Return
CPA
Cathy Pareto & Associates Coral Gables, Florida $171M AUM 25.52% 1-Year Est. Return
WA
WPG Advisers Baltimore, Maryland $170M AUM 33.45% 1-Year Est. Return
EWM
Evolution Wealth Management Fort Myers, Florida $170M AUM 19.89% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
GA
Gordian Advisors Tucson, Arizona $170M AUM 18.06% 1-Year Est. Return

Banco de Sabadell's Q4 2023 Portfolio in Review

As of Q4 2023, Banco de Sabadell held 85 positions worth $132M, up 14% from $115M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Banco de Sabadell deployed $4.35M of net new capital in Q4 2023, opening 3 new positions and adding to 30 existing holdings. Its largest new stake was Amgen: 7,816 shares worth $2.25M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Microsoft, an estimated $823K trimmed.

  • Banco de Sabadell's largest Q4 2023 buy was Amgen: 7,816 shares worth $2.25M.
  • Banco de Sabadell added most to Pfizer in Q4 2023, an estimated $1.05M increase.
  • Banco de Sabadell's biggest Q4 2023 reduction was Microsoft, cutting an estimated $823K.
  • Banco de Sabadell fully exited Baxter International in Q4 2023, selling an estimated $599K.
  • Banco de Sabadell's ten largest holdings make up 31% of its $132M portfolio in Q4 2023.
  • Banco de Sabadell opened 3 new positions and closed 3 in Q4 2023.
  • Banco de Sabadell's portfolio value rose 14% quarter-over-quarter to $132M.

Based on Banco de Sabadell's 13F filing for Q4 2023, filed 9 Feb 2024.